[1]
Boothe, K. 2016. Evaluating the Cost-effectiveness of Pharmaceuticals in Canada. Health Reform Observer – Observatoire des Réformes de Santé. 4, 1 (Mar. 2016). DOI:https://doi.org/10.13162/hro-ors.v4i1.2796.